ESR2 and Alzheimer disease: These previous findings are of interest for tibolone as a potential therapy for AD, as neuroglobin may have an intrinsic interaction with Aβ [85], and ERβ, if reduced in expression and, consequently, activity with the hormonal decline in women, may cease to exert its modulating effects on neuroglobin.